Intensive lipid-lowering therapy for early achievement of guideline-recommended LDL-cholesterol levels in patients with ST-elevation myocardial infarction ("Jena auf Ziel").

Umidakhon MakhmudovaBeasat SamadifarAurel MalokuPellumb HaxhikadrijaJens-Arndt GeilingRobert RömerBernward LauerSven Möbius-WinklerSylvia OttoP Christian SchulzeOliver Weingärtner

Published in: Clinical research in cardiology : official journal of the German Cardiac Society (2023)

Early combination therapy with a high-intensity statin and ezetimibe and escalation of lipid-lowering therapy with either bempedoic acid or PCSK9 inhibitors gets potentially all patients with STEMI on recommended ESC/EAS LDL-C targets without significant side effects.

Keyphrases

st elevation myocardial infarction
low density lipoprotein
high intensity
combination therapy
percutaneous coronary intervention
resistance training
coronary artery disease
st segment elevation myocardial infarction
fatty acid
cardiovascular disease
open label
type diabetes
body composition